Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what changes there have been in the (a) assessment and (b) management of motor neurone disease in the last 12 months.
On 24 February 2016, the National Institute for Health and Care Excellence (NICE) published a new best practice guideline on the assessment and management of motor neurone disease (MND) and in July 2016 published a corresponding Quality Standard (QS), which sets out five key markers of high quality MND care. NICE routinely reviews its guidance to ensure that it reflects the latest available evidence, and it reviewed its QS earlier this year. Both the guideline and QS, along with information about the next planned review dates for both, can be found at the following links: